Showing results (181-190 of 363) with videos related to
Sort By:
Pageof 37
Gastroenterology and Hepatology From Bed to Bench|November 27, 2020
COVID-19 prognosis: what we know of the significance and prognostic value of liver-related laboratory parameters in SARS-CoV-2 infectionDavood Bashash, Meysam Olfatifar, Farzad Hadaegh, et al.Lipids in Health and Disease|September 4, 2012
Adolescent lipoprotein classifications according to National Health and Nutrition Examination Survey (NHANES) vs. National Cholesterol Education Program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East populationMasumeh Hatami, Maryam Tohidi, Reza Mohebi, et al.Diabetology & Metabolic Syndrome|February 3, 2023
Association of triglycerides to high-density lipoprotein cholesterol ratio to identify future prediabetes and type 2 diabetes mellitus: over one-decade follow-up in the Iranian populationMaryam Tohidi, Samaneh Asgari, Abdolreza Chary, et al.Scientific Reports|August 4, 2021
Sudden cardiac death among Iranian population: a two decades follow-up of Tehran lipid and glucose studyHossein Toreyhi, Samaneh Asgari, Davood Khalili, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 2, 2025
Isolated diastolic hypertension and incident cardio-renal-metabolic multimorbidity in the Tehran Lipid and Glucose Study: comparison of ACC/AHA and ESC/NICE guideline definitionsSoroush Masrouri, Amirhossein Hasanpour, Danial Molavizadeh, et al.Diabetology & Metabolic Syndrome|January 24, 2024
The impact of obesity on different glucose tolerance status with incident cardiovascular disease and mortality events over 15 years of follow-up: a pooled cohort analysisSamaneh Asgari, Danial Molavizadeh, Kiarash Soltani, et al.International Journal of Endocrinology and Metabolism|February 20, 2026
Ambient Air Pollution and Cardiometabolic Health in the Tehran Lipid and Glucose Study: A Scoping Review of Two Decades of EvidenceAmir Hossein Hasanpour, Mohammad Javad Mansourzadeh, Alireza Khajavi, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 1, 2026
Associations between lipid parameters and incident cardio-renal-metabolic multimorbidity: The Tehran Lipid and Glucose StudySoroush Masrouri, Navid Ebrahimi, Danial Molavizadeh, et al.Frontiers in Endocrinology|June 12, 2023
Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose StudyFarzad Hadaegh, Amir Abdi, Karim Kohansal, et al.Geriatrics & Gerontology International|March 29, 2017
Metabolic mediators of the impact of general and central adiposity measures on cardiovascular disease and mortality risks in older adults: Tehran Lipid and Glucose StudySara Kazempour-Ardebili, Azra Ramezankhani, Ali Eslami, et al.Pageof 37